Azenta, Inc. — Earnings Quality Grade F
AZTA · Healthcare
Major red flags
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 87 days, change -11 days YoY
AR growth -7.8% vs revenue growth 3.6%
Revenue 3.6%, CFFO 45.1%. Cash follows revenue
Expense Quality
Inventory 5.1% vs COGS 1.5%. Normal
CapEx growth -9.5% vs revenue 3.6%. Normal
SG&A/Gross Profit = 96.8%, exceeds 70%
Gross margin 45.5%, change +1.1pp. Stable
Cash Flow Quality
CFFO < Net Income for 3 consecutive years
Small-cap context: Small-cap CFFO/NI often diverges from working-capital swings, not necessarily manipulation.
FCF $0.0B, FCF/NI = -0.69
Accruals ratio = -6.2%. Low accruals
Cash $0.3B covers debt $0.1B
Balance Sheet Health
Goodwill+Intangibles $0.8B = 47% of equity
Debt/EBITDA = 1.3x. Healthy
Other assets -50.6% vs revenue 3.6%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions positive
Goodwill+Intangibles change -1% YoY. Normal
Manipulation Score
M-Score = -2.82 (< -2.22). Unlikely manipulator
Portfolio monitoring
Monitor AZTA continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25